B & P Vision - OptiMix World

Reference Data

ISIN LI0013017780
Valor Number 1301778
Bloomberg Global ID BBG000LZQ802
Fund Name B & P Vision - OptiMix World
Fund Provider Ahead Wealth Solutions AG Vaduz, Liechtenstein
Phone: +423 239 85 00
E-Mail: fundadm@ahead.li
Web: www.ahead.li
Fund Provider Ahead Wealth Solutions AG
Representative in Switzerland 1741 Fund Solutions AG
St. Gallen
Phone: +41 58 458 48 00
Distributor(s) Acolin Fund Services AG
Zürich
Phone: +41 44 396 96 96
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Liechtenstein
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 325.88 EUR 04.02.2025
Previous Price * 322.26 EUR 03.02.2025
52 Week High * 330.21 EUR 16.07.2024
52 Week Low * 279.00 EUR 06.09.2024
NAV * 325.88 EUR 04.02.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 6,052,498
Unit/Share Assets *** 6,052,498
Trading Information SIX

Performance

YTD Performance +6.28% 31.12.2024
04.02.2025
YTD Performance (in CHF) +6.24% 31.12.2024
04.02.2025
1 month +3.87% 07.01.2025
04.02.2025
3 months +10.02% 04.11.2024
04.02.2025
6 months +16.54% 05.08.2024
04.02.2025
1 year +11.93% 05.02.2024
04.02.2025
2 years +22.06% 06.02.2023
04.02.2025
3 years +14.94% 04.02.2022
04.02.2025
5 years +19.63% 10.02.2020
04.02.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Arista Networks Inc 4.06%
Anima Holding SpA 3.73%
Bonesupport Holding AB 3.65%
Wesdome Gold Mines Ltd 3.56%
SEI Investments Co 3.52%
Daily Journal Corp 3.50%
argenx SE 3.48%
Kaken Pharmaceutical Co Ltd 3.44%
Corcept Therapeutics Inc 3.39%
Advantest Corp 3.37%
Last data update 31.12.2024

Cost / Risk

TER *** 3.71%
TER date *** 30.06.2017
Performance Fee *** 15.00%
PTR
Max. Management Fee *** 1.45%
Ongoing Charges *** 2.53%
SRRI ***
SRRI date *** 31.01.2025

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)